Literature DB >> 21820454

Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training.

Maria Summa1, Silvia Di Prisco, Massimo Grilli, Mario Marchi, Anna Pittaluga.   

Abstract

α-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) autoreceptors exist on glutamate hippocampal terminals. Aimed at investigating whether these autoreceptors traffic constitutively, (S)AMPA-evoked [(3)H]D-ASP release from synaptosomes enriched with peptides that impede the interaction of GluA2 subunits with cytosolic proteins involved in receptor movements [namely Glutamate Receptor-Interacting Protein (GRIP), Protein Interacting with C kinase 1 (PICK1), N-ethyl-maleimide-Sensitive Fusion protein NSF proteins] was monitored. (S)AMPA alone had no effect on the spontaneous release of [(3)H]D-ASP from control synaptosomes, but became efficacious in the presence of cyclothiazide or when preventing GluA2/GRIP/PICK1, but not GluA2/NSF, interaction. Hippocampal glutamatergic terminals also possess NMDA autoreceptors. 10 μM NMDA/1 μM glycine-induced [(3)H]D-ASP release was concentration-dependently increased by (S)AMPA. Cyclothiazide potentiated the 10 μM NMDA/1 μM glycine/50 μM (S)AMPA-induced [(3)H]D-ASP overflow, while NBQX halved and MK-801 abolished it, suggesting NMDA-AMPA autoreceptor cross-talk. Western Blot analysis of sub-synaptic fractions confirmed presynaptic GluN2B-GluA2/3 co-localization. Impeding GluA2/GRIP/PICK1 interaction facilitated the NMDA/glycine/(S)AMPA-induced release of [(3)H]D-ASP, while competing for GluA2/NSF interaction reduced it, indicating that NMDA receptor favours AMPA receptor insertion in synaptosomal plasmamembranes. Finally, rearing mice in enriched environment unveiled the (S)AMPA-induced release of [(3)H]D-ASP, but leaved unmodified that caused by NMDA/glycine. The NBQX-sensitive, 50 μM (S)AMPA-evoked release of [(3)H]D-ASP was insensitive to cyclothiazide and to peptide interfering with GluA2/GRIP/PICK1 interaction but was addictive to that caused by NMDA/glycine. Presynaptic GluA2/3 immunoreactivity in EE hippocampal terminals was increased, while GluN2B was unchanged. We conclude that hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo functional up-regulation in EE animals.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21820454     DOI: 10.1016/j.neuropharm.2011.07.032

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Disruption of glutamate receptor-interacting protein in nucleus accumbens enhances vulnerability to cocaine relapse.

Authors:  Lisa A Briand; Blake A Kimmey; Pavel I Ortinski; Richard L Huganir; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

2.  Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Cesare Usai; Anna Pittaluga
Journal:  Mol Neurobiol       Date:  2019-02-07       Impact factor: 5.590

3.  Short-Term Exposure to Enriched Environment in Adult Rats Restores MK-801-Induced Cognitive Deficits and GABAergic Interneuron Immunoreactivity Loss.

Authors:  Ane Murueta-Goyena; Naiara Ortuzar; Pascual Ángel Gargiulo; José Vicente Lafuente; Harkaitz Bengoetxea
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

4.  Synaptosomes and Metamodulation of Receptors.

Authors:  Anna Pittaluga; Mario Marchi
Journal:  Methods Mol Biol       Date:  2022

5.  Glutamate receptor interacting protein acts within the prefrontal cortex to blunt cocaine seeking.

Authors:  Megan M Wickens; Andre U Deutschmann; Anna G McGrath; Vinay Parikh; Lisa A Briand
Journal:  Neuropharmacology       Date:  2019-06-21       Impact factor: 5.250

6.  Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement.

Authors:  Francesca Cisani; Guendalina Olivero; Cesare Usai; Gilles Van Camp; Stefania Maccari; Sara Morley-Fletcher; Anna Maria Pittaluga
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

Review 7.  Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals.

Authors:  Mario Marchi; Massimo Grilli; Anna M Pittaluga
Journal:  Front Pharmacol       Date:  2015-04-29       Impact factor: 5.810

Review 8.  CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.

Authors:  Anna Pittaluga
Journal:  Front Immunol       Date:  2017-09-04       Impact factor: 7.561

9.  Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies.

Authors:  Fulvio Florenzano; Corsetti Veronica; Gabriele Ciasca; Maria Teresa Ciotti; Anna Pittaluga; Gunedalina Olivero; Marco Feligioni; Filomena Iannuzzi; Valentina Latina; Michele Francesco Maria Sciacca; Alessandro Sinopoli; Danilo Milardi; Giuseppe Pappalardo; De Spirito Marco; Massimiliano Papi; Anna Atlante; Antonella Bobba; Antonella Borreca; Pietro Calissano; Giuseppina Amadoro
Journal:  Oncotarget       Date:  2017-04-22

10.  Presynaptic mGlu1 Receptors Control GABAB Receptors in an Antagonist-Like Manner in Mouse Cortical GABAergic and Glutamatergic Nerve Endings.

Authors:  Matteo Vergassola; Guendalina Olivero; Francesca Cisani; Cesare Usai; Simone Bossi; Aldamaria Puliti; Anna Pittaluga
Journal:  Front Mol Neurosci       Date:  2018-09-18       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.